Back to announcement
20260206_SCPI_Tanggapan atas Permintaan Penjelasan Bursa_32025662.pdf
Other Text extracted SCPISource file signed link, expires in 15 minutes
Extracted text 2
Page 1
Go To English Page
Nomor Surat 003/CS-OPI/II/2026
Nama Perusahaan PT Organon Pharma Indonesia Tbk
Kode Emiten SCPI
Lampiran 1
Perihal Penjelasan atas Permintaan Penjelasan Bursa
Permintaan Penjelasan Bursa
Berikut kami lampirkan Penyampaian Tanggapan Perseroan atas surat yang dikirimkan oleh Bursa Efek Indonesia
tertanggal 4 February 2026 terkait Pemilik Manfaat. Terima kasih
Demikian untuk diketahui.
Hormat Kami,
PT Organon Pharma Indonesia Tbk
Arie Noviandari
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Telepon : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Nama Pengirim Arie Noviandari
Jabatan approver dua
Tanggal dan Waktu 06-02-2026 16:40
Lampiran 1. 003_CS-OPI_II_2026_Response Letter to IDX.pdf
Dokumen ini merupakan dokumen resmi PT Organon Pharma Indonesia Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT Organon Pharma Indonesia Tbk
bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 2
Go To Indonesian Page
Letter / Announcement No. 003/CS-OPI/II/2026
Issuer Name PT Organon Pharma Indonesia Tbk
Issuer Code SCPI
Attachment 1
Subject Explanation for Request for Explanation Of Indonesia Stock Exchange
Request for Explanation from the Exchange
Berikut kami lampirkan Penyampaian Tanggapan Perseroan atas surat yang dikirimkan oleh Bursa Efek Indonesia
tertanggal 4 February 2026 terkait Pemilik Manfaat. Terima kasih
Thus to be informed accordingly.
Respectfully,
PT Organon Pharma Indonesia Tbk
Arie Noviandari
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Phone : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Sender Name Arie Noviandari
Function approver dua
Date and Time 06-02-2026 16:40
Attachment 1. 003_CS-OPI_II_2026_Response Letter to IDX.pdf
This is an official document of PT Organon Pharma Indonesia Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. PT Organon Pharma Indonesia Tbk is fully responsible
for the information contained within this document.
Names mentioned 4 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Indonesia Stock Exchange
p.2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.